264 related articles for article (PubMed ID: 25814448)
1. Large-scale determination of absolute phosphorylation stoichiometries in human cells by motif-targeting quantitative proteomics.
Tsai CF; Wang YT; Yen HY; Tsou CC; Ku WC; Lin PY; Chen HY; Nesvizhskii AI; Ishihama Y; Chen YJ
Nat Commun; 2015 Mar; 6():6622. PubMed ID: 25814448
[TBL] [Abstract][Full Text] [Related]
2. Absolute Phosphorylation Stoichiometry Analysis by Motif-Targeting Quantitative Mass Spectrometry.
Tsai CF; Ku WC; Chen YJ; Ishihama Y
Methods Mol Biol; 2017; 1636():313-325. PubMed ID: 28730488
[TBL] [Abstract][Full Text] [Related]
3. Quantitative phosphoproteomic profiling of human non-small cell lung cancer tumors.
Schweppe DK; Rigas JR; Gerber SA
J Proteomics; 2013 Oct; 91():286-96. PubMed ID: 23911959
[TBL] [Abstract][Full Text] [Related]
4. Phosphoproteome profile of human lung cancer cell line A549.
Yu G; Xiao CL; Lu CH; Jia HT; Ge F; Wang W; Yin XF; Jia HL; He JX; He QY
Mol Biosyst; 2011 Feb; 7(2):472-9. PubMed ID: 21060948
[TBL] [Abstract][Full Text] [Related]
5. Global characterization of signalling networks associated with tamoxifen resistance in breast cancer.
Browne BC; Hochgräfe F; Wu J; Millar EK; Barraclough J; Stone A; McCloy RA; Lee CS; Roberts C; Ali NA; Boulghourjian A; Schmich F; Linding R; Farrow L; Gee JM; Nicholson RI; O'Toole SA; Sutherland RL; Musgrove EA; Butt AJ; Daly RJ
FEBS J; 2013 Nov; 280(21):5237-57. PubMed ID: 23876235
[TBL] [Abstract][Full Text] [Related]
6. Phosphoproteomics Reveals HMGA1, a CK2 Substrate, as a Drug-Resistant Target in Non-Small Cell Lung Cancer.
Wang YT; Pan SH; Tsai CF; Kuo TC; Hsu YL; Yen HY; Choong WK; Wu HY; Liao YC; Hong TM; Sung TY; Yang PC; Chen YJ
Sci Rep; 2017 Mar; 7():44021. PubMed ID: 28290473
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive phosphoproteome analysis of INS-1 pancreatic β-cells using various digestion strategies coupled with liquid chromatography-tandem mass spectrometry.
Han D; Moon S; Kim Y; Ho WK; Kim K; Kang Y; Jun H; Kim Y
J Proteome Res; 2012 Apr; 11(4):2206-23. PubMed ID: 22276854
[TBL] [Abstract][Full Text] [Related]
8. Identification of tyrosine-phosphorylated proteins associated with lung cancer metastasis using label-free quantitative analyses.
Wu HY; Tseng VS; Chen LC; Chang HY; Chuang IC; Tsay YG; Liao PC
J Proteome Res; 2010 Aug; 9(8):4102-12. PubMed ID: 20572634
[TBL] [Abstract][Full Text] [Related]
9. Ultradeep human phosphoproteome reveals a distinct regulatory nature of Tyr and Ser/Thr-based signaling.
Sharma K; D'Souza RC; Tyanova S; Schaab C; Wiśniewski JR; Cox J; Mann M
Cell Rep; 2014 Sep; 8(5):1583-94. PubMed ID: 25159151
[TBL] [Abstract][Full Text] [Related]
10. Integrative network analysis of the signaling cascades in seedling leaves of bread wheat by large-scale phosphoproteomic profiling.
Lv DW; Ge P; Zhang M; Cheng ZW; Li XH; Yan YM
J Proteome Res; 2014 May; 13(5):2381-95. PubMed ID: 24679076
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous quantification of protein phosphorylation sites using liquid chromatography-tandem mass spectrometry-based targeted proteomics: a linear algebra approach for isobaric phosphopeptides.
Xu F; Yang T; Sheng Y; Zhong T; Yang M; Chen Y
J Proteome Res; 2014 Dec; 13(12):5452-60. PubMed ID: 25403019
[TBL] [Abstract][Full Text] [Related]
12. Targeted phosphoproteomics of insulin signaling using data-independent acquisition mass spectrometry.
Parker BL; Yang G; Humphrey SJ; Chaudhuri R; Ma X; Peterman S; James DE
Sci Signal; 2015 Jun; 8(380):rs6. PubMed ID: 26060331
[TBL] [Abstract][Full Text] [Related]
13. Deep Phospho- and Phosphotyrosine Proteomics Identified Active Kinases and Phosphorylation Networks in Colorectal Cancer Cell Lines Resistant to Cetuximab.
Abe Y; Nagano M; Kuga T; Tada A; Isoyama J; Adachi J; Tomonaga T
Sci Rep; 2017 Sep; 7(1):10463. PubMed ID: 28874695
[TBL] [Abstract][Full Text] [Related]
14. Phosphoproteome characterization reveals that Sendai virus infection activates mTOR signaling in human epithelial cells.
Öhman T; Söderholm S; Paidikondala M; Lietzén N; Matikainen S; Nyman TA
Proteomics; 2015 Jun; 15(12):2087-97. PubMed ID: 25764225
[TBL] [Abstract][Full Text] [Related]
15. An informatics-assisted label-free quantitation strategy that depicts phosphoproteomic profiles in lung cancer cell invasion.
Wang YT; Tsai CF; Hong TC; Tsou CC; Lin PY; Pan SH; Hong TM; Yang PC; Sung TY; Hsu WL; Chen YJ
J Proteome Res; 2010 Nov; 9(11):5582-97. PubMed ID: 20815410
[TBL] [Abstract][Full Text] [Related]
16. Measurement of protein phosphorylation stoichiometry by selected reaction monitoring mass spectrometry.
Jin LL; Tong J; Prakash A; Peterman SM; St-Germain JR; Taylor P; Trudel S; Moran MF
J Proteome Res; 2010 May; 9(5):2752-61. PubMed ID: 20205385
[TBL] [Abstract][Full Text] [Related]
17. Phosphoproteomics identifies oncogenic Ras signaling targets and their involvement in lung adenocarcinomas.
Sudhir PR; Hsu CL; Wang MJ; Wang YT; Chen YJ; Sung TY; Hsu WL; Yang UC; Chen JY
PLoS One; 2011; 6(5):e20199. PubMed ID: 21637843
[TBL] [Abstract][Full Text] [Related]
18. Two Birds with One Stone: Parallel Quantification of Proteome and Phosphoproteome Using iTRAQ.
Solari FA; Kollipara L; Sickmann A; Zahedi RP
Methods Mol Biol; 2016; 1394():25-41. PubMed ID: 26700039
[TBL] [Abstract][Full Text] [Related]
19. Quantitative phospho-proteomic profiling of hepatocyte growth factor (HGF)-MET signaling in colorectal cancer.
Organ SL; Tong J; Taylor P; St-Germain JR; Navab R; Moran MF; Tsao MS
J Proteome Res; 2011 Jul; 10(7):3200-11. PubMed ID: 21609022
[TBL] [Abstract][Full Text] [Related]
20. Integrated proteomic and phosphoproteomic analyses of cisplatin-sensitive and resistant bladder cancer cells reveal CDK2 network as a key therapeutic target.
Jung JH; You S; Oh JW; Yoon J; Yeon A; Shahid M; Cho E; Sairam V; Park TD; Kim KP; Kim J
Cancer Lett; 2018 Nov; 437():1-12. PubMed ID: 30145203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
